{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T23:02:49Z","timestamp":1771542169322,"version":"3.50.1"},"reference-count":8,"publisher":"Cambridge University Press (CUP)","issue":"2","license":[{"start":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T00:00:00Z","timestamp":1513814400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can. J. Neurol. Sci."],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1017\/cjn.2017.284","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T04:21:54Z","timestamp":1513830114000},"page":"252-253","source":"Crossref","is-referenced-by-count":12,"title":["Improvement in Severe Orthostatic Hypotension Following Carbidopa Dose Reduction"],"prefix":"10.1017","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7643-9405","authenticated-orcid":false,"given":"Anthony C.W.","family":"Lau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L.","family":"Diggle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penny P.","family":"Bring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2017,12,21]]},"reference":[{"key":"S0317167117002840_ref6","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.199.149"},{"key":"S0317167117002840_ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s007020170056"},{"key":"S0317167117002840_ref3","unstructured":"Carbidopa and levodopa. In: Lexi drugs online. Hudson, OH: Lexicomp Inc.; 2017. Available from: https:\/\/online.lexi.com\/lco\/action\/doc\/retrieve\/docid\/patch_f\/7167[updated 2017; cited 8 January 2017]."},{"key":"S0317167117002840_ref1","first-page":"590","article-title":"Part 2: introduction to the pharmacotherapy of Parkinson\u2019s disease, with a focus on the use of dopaminergic agents","volume":"40","author":"DeMaagd","year":"2015","journal-title":"P T"},{"key":"S0317167117002840_ref2","volume-title":"Pathophysiologic Basic of Drug Therapy, 3E","author":"Golan","year":"2012"},{"key":"S0317167117002840_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2010.03.006"},{"key":"S0317167117002840_ref8","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"S0317167117002840_ref4","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000083721.49847.D7"}],"container-title":["Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0317167117002840","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T15:14:03Z","timestamp":1555341243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0317167117002840\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,21]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0317167117002840"],"URL":"https:\/\/doi.org\/10.1017\/cjn.2017.284","relation":{},"ISSN":["0317-1671","2057-0155"],"issn-type":[{"value":"0317-1671","type":"print"},{"value":"2057-0155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,21]]}}}